Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Visterra

Visterra
2007 FOUNDED
M&A STATUS
41-50 EMPLOYEES
M&A LATEST DEAL TYPE
$430M LATEST DEAL AMOUNT
Description

Operator of a clinical-stage biopharmaceutical company designed to treat infectious diseases caused by organisms. The company's novel platform designs and engineers antibody-based biological products for the treatment of non-infectious diseases that are not being adequately addressed, enabling the patients to seek the significant unmet need for effective therapies.

Formerly Known As
Parasol Therapeutics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Primary Office
  • 275 2nd Avenue
  • Waltham, MA 02451
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Visterra’s full profile, request a free trial.

Visterra Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 31-Aug-2018 $430M 00000 00000 Completed Generating Revenue
8. Later Stage VC (Series C) 05-Oct-2017 000.00 00000 00000 Completed Generating Revenue
7. IPO 10-Feb-2017 0000 00000 Cancelled Generating Revenue
6. Grant 29-Sep-2015 000.00 000.00 Completed Pre-Clinical Trials
5. Later Stage VC (Series B) 15-May-2014 0000 000.00 00000 Completed Pre-Clinical Trials
4. Later Stage VC (Series A) 02-Dec-2013 000.00 000.00 0000 Completed Startup
3. Debt - General 17-Sep-2010 000 000.00 Completed Startup
2. Seed Round 07-Dec-2009 $3.6M $5.64M 00.00 Completed Startup
1. Seed Round 28-Jan-2008 $2.04M $2.04M 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Visterra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 00,000,000 00.000000 00.00 00.00 00 00.00 000
Series B 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 32,447,072 $0.000100 $1 $1 1x $1 28.51%
Seed 6,178,926 $0.000100 $1 $1 1x $1 5.43%
To view this company’s complete Cap Table, request access »

Visterra Competitors (64)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kbp Biosciences Venture Capital-Backed Princeton, NJ 0000 00000000000 0000
0000 000000000000 Formerly VC-backed Geneva, Switzerland 000.00 000000&0 000.00
00000000 Formerly VC-backed Munich, Germany 000.00 000000&0 000.00
00 00000000 Venture Capital-Backed Glasgow, United Kingdom 00 000.00 0000000000 0 000.00
00000 000000000000 Formerly VC-backed San Diego, CA 00 00.00 000000&0 00.00
To view this company’s complete list of competitors, request access »

Visterra Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Allegheny Financial Group Asset Manager Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
CTI Life Sciences Fund Venture Capital Minority 000 0000 000000 0
Cycad Group Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Visterra Executive Team (15)

Name Title Board
Seat
Contact
Info
Brian Pereira MD President, Chief Executive Officer and Board Member
Chris Kiefer JD Chief Administrative Officer, General Counsel and Corporate Secretary
Zachary Shriver Ph.D Chief Scientific Officer
Todd Curtis Vice President, Finance & Controller
Obadiah Plante Ph.D Director, Research

6 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

Visterra Board Members (16)

Name Representing Role Since Contact
Info
Brian Pereira MD Visterra President, Chief Executive Officer and Board Member 000 0000
Ram Sasisekharan Ph.D Visterra Co-Founder, Scientific Founder and Board Member 000 0000

14 Former Board Members

You’re viewing 2 of 16 board members. Get the full list »